Answers are grounded in this paper and cite their sources.
Clozapine is the only pharmacological treatment effective for treatment-resistant schizophrenia, but concerns about cardiometabolic adverse effects may discourage its use. Population-level, long-term data comparing major adverse cardiovascular events (MACE) and metabolic disease progression between clozapine users (ClozUs) and non-clozapine antipsychotic users (Non-ClozUs) remain scarce. We conducted a retrospective cohort study using Hong Kong Hospital Authority electronic health records (2003–2019; follow-up through 2023), comparing incident ClozUs with Non-ClozUs matched 1:3 by age, sex, and illness duration. Primary outcomes were new-onset MACE and metabolic diseases (diabetes, hypertension, dyslipidemia, and obesity), assessed using adjusted Cox proportional-hazards models. Secondary outcomes included progression from a single metabolic condition to cardiometabolic multimorbidity or MACE; sensitivity analyses compared clozapine with olanzapine. Among 19,132 patients (mean [SD] age, 39.42 [11.85] years; 49.72% female; mean follow-up, 12.78 years), 4,783 ClozUs had risks of MACE, diabetes, and dyslipidemia comparable to Non-ClozUs, but lower risks of hypertension (adjusted hazard ratio [aHR], 0.76; 95% confidence interval [CI], 0.68–0.84) and obesity (aHR, 0.56; 95% CI, 0.46–0.69). ClozUs also had a lower rate of progression to cardiometabolic multimorbidity or MACE (32.18% vs. 41.31%; P < 0.001). Sensitivity analyses showed lower risks of hypertension, dyslipidemia, and obesity with clozapine than with olanzapine. Older age, male sex, depression, and substance use were associated with metabolic conditions among ClozUs. These findings indicate that metabolic concerns alone should not preclude clozapine treatment and support structured, individualized cardiometabolic monitoring for people receiving antipsychotics.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: